Medical Letter on the CDC & FDA


Researchers' work from National Institute for Biological Standards and Control focuses on parvovirus



Medical Letter on the CDC & FDA Library
Library Home

This article was published in Medical Letter on the CDC & FDA, which you can subscribe to online.

2008 JAN 13 -- Current study results from the report, 'Human parvovirus PARV4 in clotting factor VIII concentrates,' have been published. According to a study from Potters Bar, the United Kingdom, "Parvoviruses are small non-enveloped DNA viruses, relatively resistant to virus inactivation procedures. The recently identified human parvovirus PARV4, including a related genotype 2 virus (also termed PARV5), has been found to be a contaminant of pooled plasma used in the manufacture of plasma-derived products."

"This report describes an investigation to determine whether PARV4 is present in clotting factor concentrates. Factor VIII concentrates manufactured in the past 30-35 years were screened for PARV4 and human parvovirus B19 (B19V) sequences. Viral loads in products testing positive for PARV4 were quantified using a consensus TaqMan assay designed to a highly conserved region. DNA sequence analysis was performed to confirm the genotypes present. From a total of 175 lots of factor VIII concentrate, 28 of these contained PARV4 sequences, and in two lots both genotypes 1 and 2 were found to be present. The highest viral loads observed exceeded 10(5) copies per ml. The majority of factor VIII concentrates testing positive for PARV4 were manufactured in the 1970s and 1980s. Human B19V was also a frequent contaminant of these products. PARV4 was detected in 16% of factor VIII concentrates, particularly in older batches from the 1970s and 1980s," wrote J.F. Fryer and colleagues, National Institute for Biological Standards and Control.

The researchers concluded: "The significance in terms of the viral safety and potential transmission to recipients of these products is not yet known."

Fryer and colleagues published the results of their research in Vox Sanguinis (Human parvovirus PARV4 in clotting factor VIII concentrates. Vox Sanguinis, 2007;93(4):341-7).

For additional information, contact J.F. Fryer, National Institute for Biological Standards and Control, Division of Virology, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK.

The publisher of the journal Vox Sanguinis can be contacted at: Blackwell Publishing Ltd., 9600 Garsington Rd., Oxford OX4 2DG, Oxon, England.

Keywords: United Kingdom, Potters Bar, DNA, Parvoviridae, Parvovirus, Regulatory Actions, Viral, Viral Load, Virology, Virus.

This article was prepared by Medical Letter on the CDC & FDA editors from staff and other reports. Copyright 2008, Medical Letter on the CDC & FDA via NewsRx.com.